Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04789720 · ClinicalTrials.gov registry record · NA
Using Information Technology to Improve Outcomes for Children Living With Cancer
A NA study of Cancer, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 216
- Enrollment target
- 1
- Study location
NCT04789720: Active NA study of Cancer, sponsored by Northwestern University.
NCT04789720 is a NA study of Cancer that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 216 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04789720, a NA study of Cancer, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed study plans to develop and evaluate a patient-oriented, technology-based, symptom monitoring system that reports symptoms experienced by children with cancer to their parents and health care providers.
Primary Outcome
The adherence to the SyMon-SAYS Intervention will be evaluated by using the percentage of dyads completing the symptom assessments at all time-points (16 weeks for Group A participants and 8 weeks for Group B participants), excluding those who are off-study or deceased.
Conditions Studied
Interventions
- BEHAVIORAL Symptom Monitoring & Systematic Assessment and Reporting System in Young Survivors (SyMon-SAYS)
Study Locations (1)
Illinois
- Ann & Robert H. Lurie Childrens Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT04789720 still lists
NCT04789720 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Symptom Monitoring & Systematic Assessment and Reporting System in Young Survivors (SyMon-SAYS) is the first listed.
NCT04789720 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04789720 about?
NCT04789720 is a clinical study titled "Using Information Technology to Improve Outcomes for Children Living With Cancer". This proposed study plans to develop and evaluate a patient-oriented, technology-based, symptom monitoring system that reports symptoms experienced by children with cancer to their parents and health care providers.
What is the current status of trial NCT04789720?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2021-04-01. Estimated completion is 2025-12-31.
What conditions does trial NCT04789720 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT04789720?
The interventions under investigation include: Symptom Monitoring & Systematic Assessment and Reporting System in Young Survivors (SyMon-SAYS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04789720?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04789720 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04789720's enrollment target sits among peer trials
216 222nd of 615 higher than 394 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI